In the medulloblastoma, we observed 45 tumor‐specific pathogenic variants in 35 CNS tumor‐related genes, including PTCH1, PTCH2, and SMO, which are frequently altered in medulloblastomas (Table 1). This evidence concerns the gene SMO and central nervous system neoplasm.